ArticleCancer immunology, immunotherapy : CII2022

GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy.

Haruka Miyata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.